Atlas Venture Fund Xii, L.P. Aerovate Therapeutics, Inc. (AVTE) insider trading activity

Atlas Venture Fund Xii, L.P. is > 10% Shareholder of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 2.33 Million shares of AVTE, which is worth approximately $6.12 Million. The most recent transaction as insider was on Jul 15, 2022, when has been sold 310,388 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.33M

0% 3M change

0% 12M change

Total Value Held $6.12 Million

Atlas Venture Fund XII, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2022	SELL Other acquisition or disposition	-	310,388 Reduced 11.76%	2,327,909 Common Stock
Apr 01 2022	SELL Other acquisition or disposition	-	465,582 Reduced 15.0%	2,638,297 Common Stock
Jul 02 2021	BUY Open market or private purchase	$7,499,996 $14.0 p/Share	535,714 Added 14.72%	3,103,879 Common Stock
Jul 02 2021	BUY Conversion of derivative security	-	2,568,165 Added 50.0%	2,568,165 Common Stock

Also insider at

VIGL

Vigil Neuroscience, Inc. Healthcare

> 10% Shareholder

AVF